Related Experiment Videos
HLA-DPB1 alleles in patients with rheumatoid arthritis
D P Singal1, A Sastry, W W Buchanan
1Department of Pathology, McMaster University, Hamilton, Ontario, Canada.
Insights
Human Leukocyte Antigen (HLA)-DPB1 alleles showed no significant association with rheumatoid arthritis (RA) susceptibility in Caucasian patients. This study suggests DPB1 alleles are unlikely to be a major factor in developing RA.
Area of Science:
- Immunogenetics
- Rheumatology
- Human Leukocyte Antigen (HLA) complex
Background:
- Rheumatoid arthritis (RA) is an autoimmune disease with complex genetic underpinnings.
- Human Leukocyte Antigen (HLA) genes are known to influence autoimmune disease susceptibility.
- The role of specific HLA-DPB1 alleles in RA pathogenesis requires further investigation.
Purpose of the Study:
- To investigate the association between HLA-DPB1 allele distribution and rheumatoid arthritis (RA) in a Caucasian population.
- To compare HLA-DPB1 allele frequencies in seropositive RA, seronegative RA, and healthy controls.
Main Methods:
- Genomic DNA was extracted from 94 adult Caucasian RA patients (65 seropositive, 29 seronegative) and 40 normal controls.
- HLA-DPB1 alleles were identified using oligonucleotide typing of polymerase chain reaction (PCR)-amplified DNA.
Main Results:
- A higher prevalence of the DPB1*0402 allele was observed in seropositive RA patients.
- DPB1*0201 allele prevalence was higher in seronegative RA patients.
- These observed differences in allele frequencies between patient groups and controls were not statistically significant.
Conclusions:
- The study suggests that HLA-DPB1 alleles do not play a significant role in susceptibility to rheumatoid arthritis.
- Further research may be needed to explore other genetic factors contributing to RA development.
Abstract:
The distribution of HLA-DPB1 alleles was studied in 94 adult Caucasian RA patients (65 = seropositive, 29 = seronegative) and 40 normal controls. The DPB1 alleles were defined by oligonucleotide typing of polymerase chain (PCR)-amplified genomic DNA. The prevalence of the DPB1*0402 allele was higher in seropositive RA patients and DPB1*0201 was higher in seronegative RA patients. These differences were not significant, however. It is likely that DPB1 alleles do not play an important role in susceptibility to RA.